Company intelligence / Profile preview

Sundance Biosciences

South San Francisco, CA, United Statessundancebio.com ↗
Ownership
Private
Development stage
Other
01

Overview

Sundance Biosciences is a clinical-stage biotechnology company focused on developing next-generation immune modulators. Spun out from Neuron23 in late 2025, the company is advancing a pipeline of three oral small molecule therapies targeting TYK2, a key enzyme in immune system regulation. Its lead programs include SUN-627, a brain-penetrant TYK2 inhibitor for multiple sclerosis and neuroinflammation, and SUN-111, a peripherally-restricted inhibitor for immunology indications. Both lead candidates have completed Phase 1 clinical trials, demonstrating strong target engagement and safety profiles. Sundance is led by an experienced management team and backed by prominent investors including Westlake BioPartners and Blue Owl.

Therapeutic areas
NeurologyImmunology
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

3 assets

SUN-627

2

2 more assets in the full pipeline.

Beyond the preview

Go deeper on Sundance Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sundance Biosciences.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call